Forteo co-pay card
- Eligible patients pay as little as $4 per month with the FORTEO Co-pay Card
- Up to 24 months
Download their FORTEO co-pay card below
Patients must have commercial drug insurance for FORTEO. Offer subject to a monthly cap of wholesale acquisition cost plus usual and customary charges and a separate maximum annual benefit of $9,000. This offer is invalid for patients without commercial drug insurance or those whose prescription claims are eligible to be reimbursed, in whole or in part, by Medicare Part D, Medicaid, TRICARE or any other state or federal program. Offer void where prohibited by law and subject to change or discontinue without notice. Card activation required. Subject to additional terms and conditions, which can be found here. Offer expires 12/31/2019.
Help eligible patients lower out-of-pocket costs to as little as $4 per month for FORTEO for up to 24 months. Help your patients by downloading their card below or contact FORTEO Connect™.
Patient co-pay card
For eligible commercial patients pay as little as $4 for a month's supply of FORTEO*.
Give them a FORTEO starter kit†
Call The Lilly Answers Center (TLAC) at 1-800-LillyRx (1-800-545-5979) to receive kits
- FORTEO Travel Bag with room for their FORTEO delivery device and needles
- FORTEO User Manual
- FORTEO Patient Guide
- FORTEO Prescribing Information and Medication Guide
- FORTEO Patient Registry Form—support our study on the long-term safety of FORTEO
- FORTEO Welcome Card
Looking for Help Getting Your Patients Access?
The resources below are meant to assist in the coverage authorization and appeals process. For help with access, review our step-by-step guide to coverage.
Resources for healthcare providers
Use the resources below to explore important information you should know about FORTEO.
Find clinical information and more about FORTEO at the Lilly Medical website for healthcare professionals.
FORTEO Patient Registry
The FORTEO Patient Registry plays an important role in monitoring the long-term safety of FORTEO, including the potential risk of osteosarcoma. Visit www.forteoregistry.org for more information.
Please educate patients about the voluntary FORTEO Patient Registry and encourage them to enroll.